- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Serum Institute CEO informs Home Minister Amit Shah about COVID-19 vaccine rollout
New Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Friday said he met Union Home Minister Amit Shah and apprised him about the ongoing COVID-19 vaccine rollout in the country."It was my honour to brief you today, Shri Hon''ble @AmitShah Ji on the vaccine capabilities of our country and the ongoing rollout of vaccines in India," Poonawalla said in a tweet.In January, the...
New Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Friday said he met Union Home Minister Amit Shah and apprised him about the ongoing COVID-19 vaccine rollout in the country.
"It was my honour to brief you today, Shri Hon''ble @AmitShah Ji on the vaccine capabilities of our country and the ongoing rollout of vaccines in India," Poonawalla said in a tweet.
In January, the country''s drugs regulator had approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.
Read also: Prioritising domestic vaccine needs, asks for patience: Serum Institute of India
Apart from making efforts to meet the requirements of India, SII, the world''s largest vaccine maker, is also trying its best to balance the needs of the rest of the world.
Read also: AstraZeneca, Novavax say tie-up with Serum Institute key to mass production of Covid-19 Vaccines
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751